Basal Cell Carcinoma Superficial
📧 Sign up to get email alerts when something new happens for Basal Cell Carcinoma Superficial.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2011-07-15FDA Approved: ZYCLARA — Supplemental Application (Bausch Health US, LLC)
FDA records a supplemental application for ZYCLARA (imiquimod) from Bausch Health US, LLC, filed to update the product labeling.